Research Article
Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma
Table 4
Univariate and multivariate regression analysis of TCGA-LUAD.
| Characteristics | Univariate analysis | Multivariate analysis | HR(95% CI) | Value | HR(95% CI) | Value |
| T Stage | T1 | Reference | | | | T2 | 1.521 (1.068–2.166) | 0.020 | 1.401 (0.859–2.284) | 0.177 | T3 | 2.937 (1.746–4.941) | <0.001 | 3.378 (1.644–6.940) | <0.001 | T4 | 3.326 (1.751–6.316) | <0.001 | 1.765 (0.690–4.517) | 0.236 |
| N stage | N0 | Reference | | | | N1 | 2.382 (1.695–3.346) | <0.001 | 1.853 (1.200–2.864) | 0.005 | N2&N3 | 2.968 (2.040–4.318) | <0.001 | 1.877 (0.728–4.844) | 0.193 |
| M Stage | M0 | Reference | | | | M1 | 2.136 (1.248–3.653) | 0.006 | 1.002 (0.385–2.609) | 0.996 |
| Gender | Female | Reference | | | | Male | 1.070 (0.803–1.426) | 0.642 | | |
| Age | | | | | ≤65 | Reference | | | | >65 | 1.223 (0.916–1.635) | 0.172 | | |
| Residual tumor | R0 | Reference | | | | R1&R2 | 3.879 (2.169–6.936) | <0.001 | 2.450 (1.131–5.308) | 0.023 |
| Smoker | No | Reference | | | | Yes | 0.894 (0.592–1.348) | 0.591 | | |
| Pathologic stage | Stage I&Stage II | Reference | | | | Stage III&Stage IV | 2.664 (1.960–3.621) | <0.001 | 1.608 (0.607–4.255) | 0.339 |
|
|